Atlas Trials

Arginine Therapy for Sickle Cell Disease Pain

Clinical trial NCT02536170 · COMPLETED

Trial details

NCT number
NCT02536170
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseVaso-occlusive Pain Episode
Start date
2016-02-01
Primary completion
2021-02-21
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.